2214-3599
Published by: IOS Press
https://www.iospress.com/catalog/journals/journal-of-neuromuscular-diseases
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1017 | 72 | 144 | 23 |
The primary areas of discussion in the journal are Disease, Internal medicine, Duchenne muscular dystrophy, Pediatrics and Physical therapy. Journal of neuromuscular diseases explores topics in Disease which can be helpful for research in disciplines like MEDLINE and Bioinformatics. In it, Gastroenterology, Endocrinology and Cardiology are investigated in conjunction with one another to address concerns in Internal medicine research.
The concepts on Duchenne muscular dystrophy presented in it can also apply to other research fields, including Exon skipping, Muscular dystrophy and Pathology. Studies on Pediatrics discussed in the journal link to the field of Cohort. Physical therapy research presented in the journal encompasses a variety of subjects, including Quality of life and Clinical trial.
Spinal muscular atrophy research discussed connects with the study of Nusinersen. The research on Nusinersen discussed in Journal of neuromuscular diseases draws on the closely related field of SMA*. Discussions in Journal of neuromuscular diseases are anchored in the subject of SMA* and the similar topic of Physical medicine and rehabilitation.
The most cited publications mostly deal with topics like Duchenne muscular dystrophy, Disease, Pediatrics, Bioinformatics and Spinal muscular atrophy. The journal publications explore topics in Disease which can be helpful for research in disciplines like Muscular dystrophy, Database, Myositis and Myopathy. The journal papers address concerns in Pediatrics which are intertwined with other disciplines, such as Physical therapy and Incidence (epidemiology).
Journal of neuromuscular diseases is mainly concerned with subjects like Duchenne muscular dystrophy, Internal medicine, Disease, Dystrophin and Clinical trial. The Duchenne muscular dystrophy works featured in it incorporate elements from Bioinformatics, Exon skipping, Muscular dystrophy, Pathophysiology and Simvastatin. Topics in Internal medicine were tackled in line with various other fields like Gastroenterology, Genotype and Cardiology.
The journal explores issues in Disease which can be linked to other research areas like Physical therapy, Pediatrics and Cohort. Many of the research works in Dystrophin, specifically Dystrophin gene, closely connected to disciplines like In patient. The journal addresses concerns in Clinical trial which are intertwined with other disciplines, such as Evidence-based medicine and MEDLINE.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Journal of neuromuscular diseases (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Journal of neuromuscular diseases (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 5.69% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 40.52% were posted by at least one author from the top 10 institutions publishing in the journal. Another 3.45% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 23.28% of all publications and 32.76% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
One crucial aspect we must discuss is how the findings from the research into neuromuscular diseases have been applied in various fields, especially in the healthcare sector. Researchers and medical professionals have utilized the knowledge generated to improve disease management and patient outcomes significantly. For instance, the discoveries in Duchenne muscular dystrophy, such as exon skipping and pathophysiology, have led to the development of new therapies and drug treatments, reducing the disease's progression and improving patients' quality of life. The methods and techniques used in these studies are also relevant to other research areas, possibly opening new avenues for investigation. Insights drawn from research in internal medicine, particularly in gastroenterology, endocrinology, and cardiology, have been influential in managing patients with neuromuscular conditions who also have corresponding complications in these medical fields. Similarly, the field of pediatrics has immensely benefited from the research findings, particularly spinal muscular atrophy's early diagnosis and treatment, leading to better prognoses for affected children. Interestingly, the research findings have also had implications beyond the field of healthcare. For instance, the discipline of bioinformatics has drawn from the vast databases developed from neuromuscular diseases research to come up with new algorithms and models, fostering advancements in big data analysis and artificial intelligence. Lastly, the training and professional development of healthcare providers also owe a lot to these research findings. For example, physical therapy education, particularly in colleges and universities offering health-related degree programs such as the best nursing schools in Georgia, have integrated these research findings into their curricula, equipping future therapists with the knowledge and competencies to deliver evidence-based care to their patients with neuromuscular conditions. As we push the boundaries of scientific knowledge with ongoing research, more applications of these findings across diverse fields are projected, holding even greater promise for the future.
Jacqueline Glascock;Jacinda Sampson;Anne M. Connolly;Basil T. Darras
(2020)Craig M McDonald;Perry B Shieh;Hoda Z Abdel-Hamid;Anne M Connolly
(2021)Stefano Schiaffino;Carlo Reggiani;Takayuki Akimoto;Bert Blaauw
(2021)S.M. Salabarria;J. Nair;N. Clement;B.K. Smith
(2020)Mattia Quattrocelli;Mattia Quattrocelli;Aaron S. Zelikovich;Isabella M. Salamone;Julie A. Fischer
(2021)V A Sansone;M C Walter;S Attarian;S Delstanche
(2020)Olga Mitelman;Hoda Z. Abdel-Hamid;Barry J. Byrne;Anne M. Connolly
(2021)H.J. McMillan;B. Gerber;T. Cowling;W. Khuu
(2021)For students interested in medicine but looking for alternative or complementary pathways, exploring nursing career options can be valuable. Many accelerated programs offer flexible routes to advanced nursing roles. For those wondering how to become a np, there are streamlined programs that significantly reduce the time required to enter this high-demand profession.
Registered Nurses (RNs) aiming to advance their education might consider the fastest rn to bsn program online. These fast-track options allow RNs to obtain a Bachelor of Science in Nursing in as little as six months, improving credentials and career prospects without interrupting ongoing work commitments.
For those starting with an Associate Degree in Nursing (ADN), bridging programs provide a clear path forward. The adn to np bridge programs offer a practical route from entry-level nursing roles to Nurse Practitioner positions, which bring greater responsibility and better compensation.
Non-nurses interested in entering the nursing field at a higher level can explore the online direct entry msn programs for non-nurses. These programs enable career changers to earn a Master of Science in Nursing without prior nursing experience, accelerating entry into advanced practice.
